These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19910618)

  • 21. Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain.
    Vranken JH; van der Vegt MH; van Kan HJ; Kruis MR
    Acta Anaesthesiol Scand; 2005 May; 49(5):665-70. PubMed ID: 15836681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancer pain management--the palliative care approach].
    Michel-Nemitz J; Mazzocato C
    Rev Med Suisse; 2005 Jun; 1(25):1667-73. PubMed ID: 16117032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling cancer pain with pharmacotherapy.
    Pharo GH; Zhou L
    J Am Osteopath Assoc; 2007 Dec; 107(12 Suppl 7):ES22-32. PubMed ID: 18165374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intrathecal phenol block in a child with cancer pain--a case report].
    Shimazaki M; Egawa H; Motojima F; Fujimaki K; Hamaguchi S; Okuda Y; Kitajima T
    Masui; 2003 Jul; 52(7):756-8. PubMed ID: 12910978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates].
    Enig B
    Ugeskr Laeger; 1983 Oct; 145(42):3236-40. PubMed ID: 6197797
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subarachnoid methylprednisolone for relief of sciatic pain secondary to space-occupying lesion: a case report.
    Bernhard WN; Presbitero JV; Dolorico VN
    Anesth Analg; 1974; 53(5):744-7. PubMed ID: 4479290
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuing challenges in the management of cancer pain.
    Bruera E
    Oncology (Williston Park); 1989 Aug; 3(8 Suppl):31-4. PubMed ID: 2484298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction.
    Akin Takmaz S; Inan N; Günal S; Kaymak C; Sakalli M; Dikmen B
    Agri; 2005 Jul; 17(3):44-7. PubMed ID: 16158342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Factors associated with refractory cancer pain].
    Piguet V; Desmeules J; Allaz AF; Kondo Oestreicher M; Dayer P
    Schweiz Med Wochenschr; 1998 Feb; 128(6):208-11. PubMed ID: 9540143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Palliative care team at general hospital].
    Hashizume T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):172-5. PubMed ID: 15751628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed tomography-guided bilateral transdiscal superior hypogastric plexus neurolysis.
    Dooley J; Beadles C; Ho KY; Sair F; Gray-Leithe L; Huh B
    Pain Med; 2008 Apr; 9(3):345-7. PubMed ID: 18366511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 35. Intractable cancer pain: a new technique for attack in a patient with an implanted intrathecal infusion pump.
    Kowal AG; Staats PS
    Reg Anesth; 1997; 22(6):584. PubMed ID: 9425980
    [No Abstract]   [Full Text] [Related]  

  • 36. [Management of facial pain resulting from cancer in oral and maxillofacial surgery].
    Chiarini L; Stacca R; Bertoldi C; Malagnino F; Pollastri G; Narni F
    Minerva Stomatol; 1997; 46(1-2):27-38. PubMed ID: 9173214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical neurolysis in the treatment of pain due to cancer in cervico-facial and stomatologic pathology].
    Wilkening M; Farcy J; Walczak C; Ballereau Y
    Anesth Analg (Paris); 1977; 34(5):963-72. PubMed ID: 613867
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
    Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
    J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of cancer pain in Denmark. A questionnaire survey].
    Jensen NH; Banning AM; Jensen MB; Klee MC; Sjøgren P
    Ugeskr Laeger; 1997 Mar; 159(14):2086-90. PubMed ID: 9148532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of epidural neulolysis using ethyl alcohol and histopathologic changes in the spinal cord].
    Hayashi I; Odashiro M; Sasaki Y
    Masui; 2000 Aug; 49(8):877-80. PubMed ID: 10998880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.